Research & News

Combination ARV Use During Pregnancy and Preterm Birth Risks

May 26, 2010

A review of women started on antiretroviral therapy including protease inhibitors (PI) during pregnancy showed no significant association between the use of PI and spontaneous preterm birth. Additionally, no association was found in those women who were on ARV prior to... Read More

Exposure to ARV In Utero and Neurological Development

May 26, 2010

Review of HIV-exposed, uninfected children that were exposed to ARV while in utero showed no significant difference in scores on some cognitive indices than those not exposed to ARV. Testing was done at two years of age and scores were controlled for demographics and... Read More

Safety of HAART for HIV-Positive Pregnant Women and Their Infants

Apr 22, 2010

When highly active antiretroviral therapy (HAART) is used in conjunction with appropriate labor management, the rate of vertical HIV transmission can be as low as <1%. While these strategies have been proven effective, the question of the safety of the pharmacologic... Read More

Hotline Participates in Association of Maternal Child Health Programs (AMCHP) 2010 Conference

Apr 22, 2010

The Illinois Perinatal HIV Hotline partnered with the National Perinatal HIV Consultation and Referral Service to present an oral session in early March at the AMCHP 2010 annual conference. The session focused on the role of state and national hotlines in preventing... Read More

Factors Associated with Declining a Rapid HIV Test

Mar 04, 2010

A secondary analysis of data from the Mother-Infant Rapid Intervention at Delivery (MIRIAD) study found that decliners of rapid HIV testing in labor and delivery were more likely to have received prenatal care. Testing in labor and delivery was seen as redundant, although... Read More

Factors Associated with Prenatal Care Among Women in MIRIAD Study

Mar 02, 2010

Prenatal care allows not only for the opportunity to provide obstetrical care to women during pregnancy, but also to screen women at risk for other health conditions or complications of pregnancy, and identify medical and psychological risk factors. This study sought to... Read More

Evidence to Support Repeat Third Trimester HIV Testing for Pregnant Women

Mar 02, 2010

The authors report on 3 cases of perinatal HIV infection in central Ohio. The mothers all had negative first trimester HIV test results and were not re-screened in the third trimester of pregnancy. All had risk factors for HIV infection of which they were unaware. The... Read More

Effects of Treatment Interruption After Pregnancy

Mar 01, 2010

Guidelines for treatment of HIV in pregnancy recommend initiation of ARV therapy after the first trimester in all pregnant patients in order to reduce maternal-to-child transmission (MTCT). This therapy is often discontinued after pregnancy if patients do not otherwise meet... Read More

Opt-in Approach to Prenatal HIV Screening Inferior to Opt-out

Feb 22, 2010

A recent study of the opt-in approach to prenatal HIV screening concluded that this approach leads to inferior screening rates when compared to the opt-out approach. With opt-in screening, 29% of women were not screened for HIV during prenatal care and the approach was... Read More

Maternal ART During Pregnancy and Infant Congenital Anomalies

Feb 22, 2010

A study of infants from Argentina and Brazil enrolled in the NISDI Perinatal Study concluded that the prevalence of congenital anomalies after first trimester exposure to ART was similar to that after second and third trimester exposure. Additionally, the prevalence of... Read More